Growth Metrics

Medpace Holdings (MEDP) Cash from Operations (2016 - 2026)

Medpace Holdings filings provide 12 years of Cash from Operations readings, the most recent being 151788000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 20.62% to 151788000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 739175000.0, a 27.01% increase, with the full-year FY2025 number at 713223000.0, up 17.15% from a year prior.
  • Cash from Operations hit 151788000.0 in Q1 2026 for Medpace Holdings, down from 192652000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 246209000.0 in Q3 2025 to a low of 46256000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 136684000.0 (2022), compared with a mean of 135014705.88.
  • The widest YoY moves for Cash from Operations: up 92.8% in 2022, down 19.3% in 2022.
  • Medpace Holdings' Cash from Operations stood at 136684000.0 in 2022, then grew by 14.42% to 156395000.0 in 2023, then increased by 21.91% to 190666000.0 in 2024, then rose by 1.04% to 192652000.0 in 2025, then fell by 21.21% to 151788000.0 in 2026.
  • The last three reported values for Cash from Operations were 151788000.0 (Q1 2026), 192652000.0 (Q4 2025), and 246209000.0 (Q3 2025) per Business Quant data.